Enhancement of intestinal inflammation in mice lacking interleukin 10 by deletion of the serotonin reuptake transporter
- PMID: 20219086
- PMCID: PMC3063458
- DOI: 10.1111/j.1365-2982.2010.01479.x
Enhancement of intestinal inflammation in mice lacking interleukin 10 by deletion of the serotonin reuptake transporter
Abstract
Background: Enterochromaffin cells and enteric neurons synthesize and release serotonin (5-HT). Reuptake, mediated by a plasmalemmal transporter (SERT) terminates the action of released 5-HT. Serotonin secretion and serotonin reuptake transporter (SERT) expression have been reported to be decreased in TNBS-induced experimental colitis and in patients with ulcerative colitis. The present study was designed to utilize the transgenic deletion of SERT as a gain-of-function model to test the hypothesis that 5-HT is a pro-inflammatory mediator in experimental colitis.
Methods: Colitis was compared in animals with IL10(+/+)SERT(+/+) (wild-type), IL10(-/-)SERT(+/+), IL10(-/-)SERT(+/-), and IL10(-/-)/SERT(-/-) (double knockout) genotypes. Macroscopic and histological damage scores were evaluated after a time period of up to 15 weeks.
Key results: Serotonin reuptake transporter expression was significantly increased in the inflamed colons of IL-10(-/-) mice, which displayed intestinal damage and a minor decrement in general health. General health was significantly worse and intestinal inflammation was more severe in IL-10(-/-)SERT(+/-), and IL-10(-/-)SERT(-/-) mice than in IL-10(-/-)SERT(+/+) or wild-type animals. Regardless of the associated SERT genotype, the number of 5-HT-immunoreactive cells was decreased by approximately 55-65% in all mice lacking IL-10.
Conclusions & inferences: Our observations indicate that colitis associated with IL-10 deficient mice is enhanced when the IL-10 deficiency is combined with a SERT deficiency. The data support the concept that 5-HT is a pro-inflammatory mediator in the gut.
Conflict of interest statement
Competing interests: the authors have no competing interests.
Figures





Similar articles
-
Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice.Am J Physiol Gastrointest Liver Physiol. 2009 Mar;296(3):G685-95. doi: 10.1152/ajpgi.90685.2008. Epub 2008 Dec 18. Am J Physiol Gastrointest Liver Physiol. 2009. PMID: 19095763
-
The Onset and Progression of Chronic Colitis Parallels Increased Mucosal Serotonin Release via Enterochromaffin Cell Hyperplasia and Downregulation of the Serotonin Reuptake Transporter.Inflamm Bowel Dis. 2018 Apr 23;24(5):1021-1034. doi: 10.1093/ibd/izy016. Inflamm Bowel Dis. 2018. PMID: 29668991
-
Serotonin transporter function and expression are reduced in mice with TNBS-induced colitis.Neurogastroenterol Motil. 2005 Aug;17(4):565-74. doi: 10.1111/j.1365-2982.2005.00673.x. Neurogastroenterol Motil. 2005. PMID: 16078946
-
The genetics of the serotonin transporter and irritable bowel syndrome.Trends Mol Med. 2008 Jul;14(7):295-304. doi: 10.1016/j.molmed.2008.05.001. Epub 2008 Jun 10. Trends Mol Med. 2008. PMID: 18550438 Review.
-
Interplay between Serotonin, Immune Response, and Intestinal Dysbiosis in Inflammatory Bowel Disease.Int J Mol Sci. 2022 Dec 9;23(24):15632. doi: 10.3390/ijms232415632. Int J Mol Sci. 2022. PMID: 36555276 Free PMC article. Review.
Cited by
-
Role of gut microbiota in cardiovascular diseases.World J Cardiol. 2020 Apr 26;12(4):110-122. doi: 10.4330/wjc.v12.i4.110. World J Cardiol. 2020. PMID: 32431782 Free PMC article. Review.
-
Association of Serotonin Transporter Promoter Polymorphism (5HTTLPR) with Microscopic Colitis and Ulcerative Colitis: Time to Be AsSERTive?Dig Dis Sci. 2015 Apr;60(4):819-21. doi: 10.1007/s10620-015-3598-8. Epub 2015 Mar 3. Dig Dis Sci. 2015. PMID: 25732715 Free PMC article. No abstract available.
-
The overlap in the genetic pathogenesis of ulcerative colitis and irritable bowel syndrome.Dig Dis Sci. 2013 Dec;58(12):3379-3381. doi: 10.1007/s10620-013-2936-y. Dig Dis Sci. 2013. PMID: 24233129 No abstract available.
-
Serotonin is an endogenous regulator of intestinal CYP1A1 via AhR.Sci Rep. 2018 Apr 17;8(1):6103. doi: 10.1038/s41598-018-24213-5. Sci Rep. 2018. PMID: 29666456 Free PMC article.
-
Metabolic kinetics of 5-hydroxytryptamine and the research targets of functional gastrointestinal disorders.Dig Dis Sci. 2014 Nov;59(11):2642-8. doi: 10.1007/s10620-014-3244-x. Epub 2014 Jun 12. Dig Dis Sci. 2014. PMID: 24916714 Review.
References
-
- Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427–34. - PubMed
-
- De Schepper HU, De Man JG, Moreels TG, Pelckmans PA, De Winter BY. Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease - clinical relevance and pathophysiological mechanisms. Aliment Pharmacol Ther. 2008;27:621–37. - PubMed
-
- Kraneveld AD, Rijnierse A, Nijkamp FP, Garssen J. Neuro-immune interactions in inflammatory bowel disease and irritable bowel syndrome: future therapeutic targets. Eur J Pharmacol. 2008;585:361–74. - PubMed
-
- Askenase PW, Herzog WR, Millet I, et al. Serotonin initiation of delayed-type hypersensitivity: mediation by a primitive Thy-1+ antigen-specific clone or by specific monoclonal IgE antibody. Skin Pharmacol. 1991;4(Suppl 1):25–42. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources